AstraZenca's new drug for stroke conducting phase IIB study in Korea
The clinical study for NXY-059 (brand name: Cerovive) will be performed in 25 countries including Europe, America and Au...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
